Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6951–7000 of 18419
to replace Erik Blum, the Company’s Chief Executive Officer, who was also serving as SMCE’s Interim CFO.
Mr. Reeves replaces Deanna White who has served as the Company’s Chief Financial Officer since December 2022.
the Company announced that Oliver Reeves accepted an offer to become the Company’s Chief Financial Officer effective January 1, 2024
Nathan Bennett, the current Corporate Controller of the Company, will be appointed as Chief Accounting Officer and Interim Chief Financial Officer of the Company effective January 1, 2024.
Tom Brock will cease to be the Chief Financial Officer of Energy Fuels Inc. ("Energy Fuels" or the "Company") effective December 31, 2023.
On December 21, 2023, the Company appointed Pengfei Xie, our Senior Advisor, as acting Chief Financial Officer.
Drew D. Hall Chief Executive Officer, Chief Financial Officer
following Scott J. Leffler’s previously announced departure as Chief Financial Officer.
On December 22, 2023, the Board of Directors of Clover Health Investments, Corp. (the “Company”) appointed Mr. Terrence Ronan as Interim Chief Financial Officer, including as principal financial officer and principal accounting officer, effective as of January 27, 2024.
the Board appointed Steven Vontur, the current Controller and Principal Accounting Officer of the Company, to serve as the Company’s Interim Chief Financial Officer, effective as of January 26, 2024.
Erik Sallee, the Chief Financial Officer of the Company informed the Company of his intention to resign from his position with the Company and its subsidiaries, effective as of January 26, 2023, for family and personal reasons
On December 20, 2023, the Company accepted the resignation of Mr. Stewart F.B. Baker as Executive Vice President, Chief Financial Officer and principal accounting officer of Inspired Entertainment, Inc.
Effective December 20, 2023, the Board of Directors of the Company appointed Marilyn Jentzen, age 57, as the Interim Chief Financial Officer of the Company.
On December 21, 2023, Altisource Asset Management Corporation (the "Company") announced that William C. Erbey as the new Chief Executive Officer of the Company. In addition, the Board of Directors of the Company has appointed Mr. Erbey as its Chairman effective as of December 21, 2023.
On December 20, 2023, Jade Barnwell resigned as Chief Financial Officer of the registrant (“Laser Photonics”).
On December 22, 2023, Life Time Group Holdings, Inc. (the “Company”) agreed with Robert Houghton, the Company’s Executive Vice President and Chief Financial Officer, that Mr. Houghton will resign from his position as Chief Financial Officer effective as of December 31, 2023 and will cease his service to the Company effective January 5, 2024.
The Company has appointed Erik Weaver, the Company’s Senior Vice President and Controller, to the additional position of interim Chief Financial Officer effective January 1, 2024.
On December 19, 2023, Adam Laponis notified Eargo, Inc. (“Eargo” or the “Company”) that he will step down as Chief Financial Officer and depart Eargo on January 5, 2024.
On December 19, 2023, Eargo appointed Mark Thorpe as Chief Financial Officer, effective January 5, 2024, to succeed Mr. Laponis.
Mr. Karaivanov’s election to the Board is part of the previously announced succession plan in which Mr. Karaivanov will assume the role of President and Chief Executive Officer of the Company and the Bank effective as of January 1, 2024.
effective January 1, 2024, Daniel C. Bartok, will step down from his role as the President and Chief Executive Officer of Forestar Group Inc.
Mr. Cavanagh will succeed Mr. Jeffrey Stoops as President and Chief Executive Officer, effective January 1, 2024.
On December 18, 2023, Selectis Health, Inc., a Utah corporation (the “Company”) appointed Jim Creamer as Interim Chief Financial Officer and Clifford Neuman to its board of directors.
On December 22, 2023, Trulieve Cannabis Corp. (the “Company”) announced the appointment of Wes Getman as the Company’s Chief Financial Officer, effective January 1, 2024.
On December 14, 2023, the Company’s Board of Directors appointed Edward Honour as Chief Executive Officer (CEO)
On December 14, 2023, Erik Nelson resigned chief financial officer and President of the Company. Mr. Nelson remains Corporate Secretary.
(b) Departure of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Effective as of the Effective Date, Mr. Frakes, Chief Financial Officer of the Company, was appointed as (i) Interim Chief Executive Officer of the Company, replacing Dr. Fisher, and (ii) a member of the Board of Directors of the Company
On December 22, 2023, the Board appointed Ryan Spick to serve as the Company’s Principal Executive Officer and Chief Financial Officer effective as of December 22, 2023.
On December 15, 2023, R. Bryan Riggsbee, Chief Financial Officer and principal financial officer of Myriad Genetics, Inc. (the “Company”) and the Company mutually reached an agreement that Mr. Riggsbee would step down from such position, effective upon the earlier of (1) the date that a new Chief Financial Officer and principal financial officer commences his or her employment at the Company and (2) January 31, 2024.
On December 15, 2023, the Board appointed Scott J. Leffler (“Mr. Leffler”) as the Company's Chief Financial Officer and principal financial officer, effective as of his first date of employment, January 29, 2024.
Ms. Krezmer’s position changed to President, Chief Executive Officer and Chief Financial Officer
Mr. Bryant, age 65, has been the Company’s Senior Vice President, Chief Financial Officer and Treasurer since June 2006 through his planned retirement effective on December 31, 2023
Mr. Bassell’s tenure as the Company’s Chief Financial Officer (principal financial and accounting officer) will conclude upon the effectiveness of Mr. Giammatteo’s appointment as Chief Financial Officer on January 2, 2024.
appointed Mr. Robb Giammatteo, as Executive Vice President and Chief Financial Officer (principal financial and accounting officer), effective January 2, 2024.
Effective upon the consummation of the Business Combination, the Company entered into an amended and restated employment agreement with Gary Strahan, its Chief Executive Officer, Steve Winch, its President, and Peter Baird, its Chief Financial Officer.
Effective upon the consummation of the Business Combination, the Company entered into an amended and restated employment agreement with Gary Strahan, its Chief Executive Officer, Steve Winch, its President, and Peter Baird, its Chief Financial Officer.
Mr. Tom Brodmerkel has resigned from the Board of Directors and as CFO of Mitesco as of December 15, 2023
Mr. Mack Leath , age 66, will serve as CEO, CFO and Chairman of the Board of Directors.
Mr. Larry Diamond resigned from all positions including the Board of Directors, CEO of Mitesco and all positions related to The Good Clinic, LLC and its sole member Mitesco N.A. LLC as of December 19, 2023, effective December 29, 2023
Robert E. Claypoole has been appointed as the Company’s President and Chief Executive Officer, and as a Class III director of the Company, effective January 10, 2024
succeeding Anthony P. Bihl III, the Company’s current Interim President and Chief Executive Officer, in such roles.
BCB Bancorp, Inc. (the “Company”), and its wholly owned subsidiary BCB Community Bank (the “Bank”), each appointed Michael A. Shriner as its President and Chief Executive Officer, effective January 1, 2024
On December 18, 2023, the Board of Directors (the “Board”) of the Company appointed Norman L. Miller, previously the Interim President and Chief Executive Officer, to the position of President and Chief Executive Officer effective immediately.
the Board promoted Mr. Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer
On December 21, 2023, C.H. Robinson Worldwide, Inc. (the “Company”) announced that Michael P. Zechmeister will be departing from his position as Chief Financial Officer of the Company.
the Board of Directors of the Company (the “Board”) has appointed Peter M. Carlson to the position of Chief Financial Officer, effective January 3, 2024.
Upon commencement of Mr. Carlson’s employment with the Company, Nils Windler, who has been serving as Chief Financial Officer of the Company since 2021, will remain with the Company to work closely with Mr. Carlson, support an orderly transition of responsibility and provide financial accounting support to the Company.
On December 20, 2023, Dozy Mmobuosi, who accepted the position of Group Interim Co-CEO on September 15, 2023, has temporarily stepped down as Interim Co-Chief Executive Officer and Member of the Board of Directors in connection with an order sought by the Securities & Exchange Commission
The Company’s other interim co-CEO, Mr. Ken Denos, will serve as its interim group CEO until further notice.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.